Provided by Tiger Trade Technology Pte. Ltd.

Edwards Lifesciences

89.79
-0.0400-0.04%
Post-market: 89.790.00000.00%19:52 EDT
Volume:2.82M
Turnover:253.16M
Market Cap:51.77B
PE:52.23
High:90.37
Open:89.89
Low:88.79
Close:89.83
52wk High:96.29
52wk Low:72.30
Shares:576.54M
Float Shares:575.03M
Volume Ratio:1.01
T/O Rate:0.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.72
EPS(LYR):1.83
ROE:9.18%
ROA:8.37%
PB:4.88
PE(LYR):48.99

Loading ...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Edwards Lifesciences (EW), Encompass Health (EHC) and Moderna (MRNA)

TIPRANKS
·
Jun 26

Edwards Lifesciences Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jun 25

Movement Alert|Edwards Lifesciences Rises 3.53% in Regular Trading, CMS TAVR National Coverage Determination Memo Continues to Serve as Positive Catalyst

Market Focus
·
Jun 24

Carvolix raises EUR 10 million in private placement at EUR 3.36 per share

Reuters
·
Jun 24

Edwards Lifesciences Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jun 23

Edwards Lifesciences CEO Bernard Zovighian disposes of 523 common shares worth $45,979.16

Reuters
·
Jun 18

Edwards Lifesciences Corp. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Jun 18

BTIG Sticks to Their Buy Rating for Edwards Lifesciences (EW)

TIPRANKS
·
Jun 17

Movement Alert|Edwards Lifesciences Rises 3.51% in Regular Trading, CMS Releases Favorable TAVR National Coverage Decision Memo

Market Focus
·
Jun 17

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

Reuters
·
Jun 17

Edwards Lifesciences Seen Benefiting From CMS Transcatheter Aortic Valve Replacement Rule, RBC Says

MT Newswires Live
·
Jun 16

Edwards Lifesciences Price Target Maintained With a $100.00/Share by RBC Capital

Dow Jones
·
Jun 16

Leerink ‘incrementally positive’ on Edwards Lifesciences after TAVR NCD proposal

TIPRANKS
·
Jun 16

RBC Capital Sticks to Its Buy Rating for Edwards Lifesciences (EW)

TIPRANKS
·
Jun 16

Edwards Lifesciences Buy Rating Reaffirmed as Favorable TAVR Policy Update Supports Growth and $100 Price Target Maintained

TIPRANKS
·
Jun 16

Analysts Conflicted on These Healthcare Names: Edwards Lifesciences (EW), Xencor (XNCR) and Definitive Healthcare Corp (DH)

TIPRANKS
·
Jun 16

Edwards Lifesciences Corp. Stock Rises Monday, Still Underperforms Market

Dow Jones
·
Jun 16

Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ) and Edwards Lifesciences (EW)

TIPRANKS
·
Jun 12

Edwards Lifesciences Set to Benefit from TAVR Coverage Update, RBC Says

MT Newswires Live
·
Jun 11

Edwards Lifesciences’ HPI Care Trial Posts Results, Offering Fresh Signals for Predictive Monitoring Investors

TIPRANKS
·
Jun 11